The IFN signature seems to be very sensitive to differentiate monogenic type I interferonopathies from inflammasomopathies and also polygenic pathologies predominantly IFN mediated (such as SLE) by pathologies whose inflammatory component is different from IFN, such as non-systemic JIA. Here, IFNA1 is linked to systemic lupus erythematosus.